EDGAR Filing Documents for 0001144204-17-038121

Form 8-K - Current report:

SEC Accession No. 0001144204-17-038121

Filing Date

2017-07-25

Accepted

2017-07-25 16:59:11

Documents

Period of Report

2017-07-25

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	v471411_8k.htm	8-K	25666
2	EXHIBIT 4.1	v471411_ex4-1.htm	EX-4.1	520366
3	EXHIBIT 4.2	v471411_ex4-2.htm	EX-4.2	26059
4	EXHIBIT 4.4	v471411_ex4-4.htm	EX-4.4	41051
5	EXHIBIT 10.1	v471411_ex10-1.htm	EX-10.1	131940
6	EXHIBIT 10.2	v471411_ex10-2.htm	EX-10.2	79548
7	EXHIBIT 99.1	v471411_ex99-1.htm	EX-99.1	10512
8	GRAPHIC	pg40img1_ex4-3.jpg	GRAPHIC	3505
9	GRAPHIC	pg41img1_ex4-3.jpg	GRAPHIC	4264
10	GRAPHIC	pg42img1_ex4-3.jpg	GRAPHIC	4381
11	GRAPHIC	pg43img1_ex4-3.jpg	GRAPHIC	4440
12	GRAPHIC	pg45img1_ex4-3.jpg	GRAPHIC	3848
13	GRAPHIC	pg46img1_ex4-3.jpg	GRAPHIC	6089
14	GRAPHIC	pg46img1_ex99-1.jpg	GRAPHIC	11335
	Complete submission text file	0001144204-17-038121.txt		889871

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100

Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488

Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)